July 15, 2011

Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER

Key Points

Key points are not available for this paper at this time.

Abstract

For patients with HER2-positive MBC evaluated in registHER, the use of trastuzumab, chemotherapy, and surgery following CNS metastases were each associated with longer survival.

Bookmark

Cite This Study

Brufsky et al. (Fri,) studied this question.

synapsesocial.com/papers/69dd67f87dbdc4ad1440c8c4 https://doi.org/https://doi.org/10.1158/1078-0432.ccr-10-2962

Bookmark